Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11127725 | 1.00 | CYP4F2 (0.31) | CYP4F2CYP4A11 | |
| SCHEMBL11238651 | 1.00 | CYP4F2 (0.31) | CYP4F2CYP4A11 | |
| SCHEMBL10881566 | 0.80 | CYP4F2 (0.36) | CYP4F2CYP4A11 | |
| SCHEMBL20365508 | 0.80 | CYP4F2 (0.36) | CYP4F2CYP4A11 | |
| SCHEMBL34475860 | 0.77 | — | — | |
| Ethylene Glycol SCHEMBL7118182 | 0.75 | LMNA (0.38) | CYP4F2CYP4A11 | |
| Ethylene Glycol SCHEMBL5667972 | 0.75 | LMNA (0.38) | CYP4F2CYP4A11 | |
| Ethylene Glycol SCHEMBL8416280 | 0.74 | LMNA (0.37) | CYP4F2CYP4A11 | |
| Ethylene Glycol SCHEMBL1509039 | 0.74 | LMNA (0.37) | CYP4F2CYP4A11 | |
| SCHEMBL11753480 | 0.73 | CYP4F2 (0.33) | CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4317942-A | Odoriferous 2-alkoxyethyl-cycloalkyl-ethers | CHEMISCHE WERKE HUELS, AKTIENGESELLSCHAFT (DE) | 1982-03-02 | — | — | US | disclosed |
| EP-0022462-B1 | 2-ALKOXYETHYL-CYCLOALKYL-ETHERS, COMPOSITIONS CONTAINING THESE, AND THEIR UTILIZATION FOR THE PREPARATION OF ODORANT COMPOSITIONS | CHEMISCHE WERKE HÜLS AG (DE) | 1981-11-25 | — | — | EP | disclosed |
| EP-0022462-A1 | 2-Alkoxyethyl-cycloalkyl-ethers, compositions containing these, and their utilization for the preparation of odorant compositions | CHEMISCHE WERKE HÜLS AG (DE) | 1981-01-21 | — | — | EP | disclosed |